Gina Jerome

4.0k total citations · 1 hit paper
24 papers, 1.7k citations indexed

About

Gina Jerome is a scholar working on Physiology, Organic Chemistry and Biophysics. According to data from OpenAlex, Gina Jerome has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 7 papers in Organic Chemistry and 6 papers in Biophysics. Recurrent topics in Gina Jerome's work include Nitric Oxide and Endothelin Effects (14 papers), Electron Spin Resonance Studies (6 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Gina Jerome is often cited by papers focused on Nitric Oxide and Endothelin Effects (14 papers), Electron Spin Resonance Studies (6 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Gina Jerome collaborates with scholars based in United States, Netherlands and Spain. Gina Jerome's co-authors include William M. Moore, Mark G. Currie, R. Keith Webber, Foe S. Tjoeng, Thomas P. Misko, Pamela T. Manning, Jane R. Connor, Yo‐El S. Ju, Courtney L. Sutphen and Anne M. Fagan and has published in prestigious journals such as Brain, Annals of Neurology and Journal of Medicinal Chemistry.

In The Last Decade

Gina Jerome

23 papers receiving 1.7k citations

Hit Papers

Slow wave sleep disruption increases cerebrospinal fluid ... 2017 2026 2020 2023 2017 100 200 300 400

Peers

Gina Jerome
Gina Jerome
Citations per year, relative to Gina Jerome Gina Jerome (= 1×) peers Shigenori Ohkawa

Countries citing papers authored by Gina Jerome

Since Specialization
Citations

This map shows the geographic impact of Gina Jerome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gina Jerome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gina Jerome more than expected).

Fields of papers citing papers by Gina Jerome

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gina Jerome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gina Jerome. The network helps show where Gina Jerome may publish in the future.

Co-authorship network of co-authors of Gina Jerome

This figure shows the co-authorship network connecting the top 25 collaborators of Gina Jerome. A scholar is included among the top collaborators of Gina Jerome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gina Jerome. Gina Jerome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ly, Cindy V., L. Randall Koenig, Jon Christensen, et al.. (2019). Tau positron emission tomography imaging in C9orf72 repeat expansion carriers. European Journal of Neurology. 26(9). 1235–1239. 2 indexed citations
2.
Schnute, Mark E., Matthew D. McReynolds, Jill Chrencik, et al.. (2017). Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits. Journal of Medicinal Chemistry. 60(6). 2562–2572. 38 indexed citations
3.
Ju, Yo‐El S., Sharon Ooms, Courtney L. Sutphen, et al.. (2017). Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels. Brain. 140(8). 2104–2111. 425 indexed citations breakdown →
4.
Ly, Cindy V., Helen Beaumont, Brian A. Gordon, et al.. (2017). [O3–03–05]: IN VIVO TAU IMAGING BY POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSIONS. Alzheimer s & Dementia. 13(7S_Part_18). 1 indexed citations
5.
Walker, Daniel P., Natasha M. Kablaoui, Jeffrey A. Scholten, et al.. (2012). Synthesis and biological evaluation of substituted benzoxazoles as inhibitors of mPGES-1: Use of a conformation-based hypothesis to facilitate compound design. Bioorganic & Medicinal Chemistry Letters. 23(4). 1120–1126. 25 indexed citations
6.
Walker, Daniel P., Yvette M. Fobian, John R. Springer, et al.. (2012). Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation. Bioorganic & Medicinal Chemistry Letters. 23(4). 1114–1119. 41 indexed citations
7.
Trujillo, John I., James R. Kiefer, Wei Huang, et al.. (2012). Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): A tale of two waters. Bioorganic & Medicinal Chemistry Letters. 22(11). 3795–3799. 18 indexed citations
8.
Hallinan, E. Ann, Timothy J. Hagen, William M. Moore, et al.. (2004). 5-Fluorinated l-Lysine Analogues as Selective Induced Nitric Oxide Synthase Inhibitors. Journal of Medicinal Chemistry. 47(4). 900–906. 16 indexed citations
9.
Hallinan, E. Ann, Steven W. Kramer, William M. Moore, et al.. (2003). 4-Fluorinatedl-lysine analogs as selective i-NOS inhibitors: methodology for introducing fluorine into the lysine side chain. Organic & Biomolecular Chemistry. 1(20). 3527–3534. 37 indexed citations
10.
Hallinan, E. Ann, Barnett S. Pitzele, William M. Moore, et al.. (2002). Synthesis and Biological Characterization of L-N6-(1-Iminoethyl)lysine 5-Tetrazole-amide, a Prodrug of a Selective iNOS Inhibitor. Journal of Medicinal Chemistry. 45(8). 1686–1689. 64 indexed citations
11.
Hagen, Timothy J., William M. Moore, Gina Jerome, et al.. (2002). 3-Hydroxy-4-methyl-5-pentyl-2-iminopyrrolidine: A potent and highly selective inducible nitric oxide synthase inhibitor. Bioorganic & Medicinal Chemistry Letters. 12(22). 3337–3339. 17 indexed citations
12.
Pitzele, Barnett S., Timothy J. Hagen, Kam F. Fok, et al.. (2002). Syntheses of new conformationally constrainedS‐[2‐[(1‐iminoethyl)amino] ethyl]homocysteine derivatives as potential nitric oxide synthase inhibitors. Heteroatom Chemistry. 13(1). 77–83. 5 indexed citations
13.
Massa, Mark A., Barnett S. Pitzele, Gina Jerome, et al.. (2000). Syntheses of new racemicNG-(1-iminoethyl)phosphalysine derivatives as potential inhibitors of nitric oxide synthase. Heteroatom Chemistry. 11(7). 505–511. 2 indexed citations
15.
Webber, R. Keith, William M. Moore, Jane R. Connor, et al.. (1998). Substituted 2-Iminopiperidines as Inhibitors of Human Nitric Oxide Synthase Isoforms. Journal of Medicinal Chemistry. 41(1). 96–101. 38 indexed citations
16.
Hagen, Timothy J., Steven W. Kramer, Kam F. Fok, et al.. (1998). 2-Iminopyrrolidines as Potent and Selective Inhibitors of Human Inducible Nitric Oxide Synthase. Journal of Medicinal Chemistry. 41(19). 3675–3683. 54 indexed citations
17.
Moore, William M., R. Keith Webber, Kam F. Fok, et al.. (1996). 2-Iminopiperidine and Other 2-Iminoazaheterocycles as Potent Inhibitors of Human Nitric Oxide Synthase Isoforms. Journal of Medicinal Chemistry. 39(3). 669–672. 77 indexed citations
18.
Connor, Jane R., Pamela T. Manning, Steven L. Settle, et al.. (1995). Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. European Journal of Pharmacology. 273(1-2). 15–24. 259 indexed citations
19.
Moore, William M., R. Keith Webber, Gina Jerome, et al.. (1994). L-N6-(1-Iminoethyl)lysine: A Selective Inhibitor of Inducible Nitric Oxide Synthase. Journal of Medicinal Chemistry. 37(23). 3886–3888. 394 indexed citations
20.
Bertenshaw, Stephen R., Roland S. Rogers, Michael Stern, et al.. (1993). Phosphorus-containing inhibitors of endothelin converting enzyme: effects of the electronic nature of phosphorus on inhibitor potency. Journal of Medicinal Chemistry. 36(1). 173–176. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026